Skip to main content

Llorens Pharmaceutical Corp.

No ongoing recalls currently shown

Based on the official records currently available to Public Health Trace, no recalls naming Llorens Pharmaceutical Corp. are currently shown as ongoing. The 1 record below is a historical recall record.

Public Health Trace has 1 recall naming Llorens Pharmaceutical Corp. as the recalling firm, republished from official FDA and USDA sources.

Recall history - 1 terminated record

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20171
Download CSV

FDA Recall TerminatedTerminated: April 3, 2019Historical recordClass II

Urin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, Methylene Blue 10.8 mg, Hyoscyamine Sulfate 0.12 mg, Rx Only, 100-count bottle, Manufactured For: Llorens Pharmaceutical Corp., International Division, Miami, FL 33166. NDC: 54859-701-10

by Llorens Pharmaceutical Corp.

Reason
Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.
Published
November 22, 2017
Distribution
Puerto Rico

View recall →

Showing 1–1 of 1 results

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name Llorens Pharmaceutical Corp. as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.